Organ Physiological Microsystem refers to a system built in vitro similar to the connections between various human tissues and organs. Each system is designed to simulate the structure and function of human organs or internal organ regions, and is connected through a microfluidic system. They can simulate and study the interactions between drugs and cells, cells and cells, and organs and organs in vitro with great physiological accuracy. Organ Physiological Microsystem provides powerful tools for studying physiology, disease modeling, drug discovery, and personalized medicine.
The global Organ Physiological Microsystem market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淥rgan Physiological Microsystem Industry Forecast鈥� looks at past sales and reviews total world Organ Physiological Microsystem sales in 2022, providing a comprehensive analysis by region and market sector of projected Organ Physiological Microsystem sales for 2023 through 2029. With Organ Physiological Microsystem sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Organ Physiological Microsystem industry.
This Insight Report provides a comprehensive analysis of the global Organ Physiological Microsystem landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Organ Physiological Microsystem portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Organ Physiological Microsystem market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Organ Physiological Microsystem and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Organ Physiological Microsystem.
United States market for Organ Physiological Microsystem is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Organ Physiological Microsystem is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Organ Physiological Microsystem is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Organ Physiological Microsystem players cover Emulate, Draper Laboratory, Mimetas, TissUse, CN Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Organ Physiological Microsystem market by product type, application, key players and key regions and countries.
Segmentation by Type:
Single-organ System
Multi-organ System
Segmentation by Application:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Single-organ System
Multi-organ System
Segmentation by Application:
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Emulate
Draper Laboratory
Mimetas
TissUse
CN Bio
Hesperos
Nortis
Micronit
Kirkstall
Bi/ond
Cherry Biotech
Altis Biosystems
SynVivo
NETRI
Xona Microfluidics
InSphero
AlveoliX
BEOnchip
BiomimX
Aracari
Lena Biosciences
Newcells Biotech
React4Life
TNO
Beijing Daxiang Biotech
Accurate International Biotechnology
D1med
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Organ Physiological Microsystem 麻豆原创 Size 2019-2030
2.1.2 Organ Physiological Microsystem 麻豆原创 Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Organ Physiological Microsystem by Country/Region, 2019, 2023 & 2030
2.2 Organ Physiological Microsystem Segment by Type
2.2.1 Single-organ System
2.2.2 Multi-organ System
2.3 Organ Physiological Microsystem 麻豆原创 Size by Type
2.3.1 Organ Physiological Microsystem 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Organ Physiological Microsystem 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Organ Physiological Microsystem Segment by Application
2.4.1 Pharmaceutical and Biotechnology Companies
2.4.2 Academic and Research Institutes
2.4.3 Others
2.5 Organ Physiological Microsystem 麻豆原创 Size by Application
2.5.1 Organ Physiological Microsystem 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Organ Physiological Microsystem 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Organ Physiological Microsystem 麻豆原创 Size by Player
3.1 Organ Physiological Microsystem 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Organ Physiological Microsystem Revenue by Player (2019-2024)
3.1.2 Global Organ Physiological Microsystem Revenue 麻豆原创 Share by Player (2019-2024)
3.2 Global Organ Physiological Microsystem Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Organ Physiological Microsystem by Region
4.1 Organ Physiological Microsystem 麻豆原创 Size by Region (2019-2024)
4.2 Global Organ Physiological Microsystem Annual Revenue by Country/Region (2019-2024)
4.3 Americas Organ Physiological Microsystem 麻豆原创 Size Growth (2019-2024)
4.4 APAC Organ Physiological Microsystem 麻豆原创 Size Growth (2019-2024)
4.5 Europe Organ Physiological Microsystem 麻豆原创 Size Growth (2019-2024)
4.6 Middle East & Africa Organ Physiological Microsystem 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Organ Physiological Microsystem 麻豆原创 Size by Country (2019-2024)
5.2 Americas Organ Physiological Microsystem 麻豆原创 Size by Type (2019-2024)
5.3 Americas Organ Physiological Microsystem 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Organ Physiological Microsystem 麻豆原创 Size by Region (2019-2024)
6.2 APAC Organ Physiological Microsystem 麻豆原创 Size by Type (2019-2024)
6.3 APAC Organ Physiological Microsystem 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Organ Physiological Microsystem 麻豆原创 Size by Country (2019-2024)
7.2 Europe Organ Physiological Microsystem 麻豆原创 Size by Type (2019-2024)
7.3 Europe Organ Physiological Microsystem 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Organ Physiological Microsystem by Region (2019-2024)
8.2 Middle East & Africa Organ Physiological Microsystem 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Organ Physiological Microsystem 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Organ Physiological Microsystem 麻豆原创 Forecast
10.1 Global Organ Physiological Microsystem Forecast by Region (2025-2030)
10.1.1 Global Organ Physiological Microsystem Forecast by Region (2025-2030)
10.1.2 Americas Organ Physiological Microsystem Forecast
10.1.3 APAC Organ Physiological Microsystem Forecast
10.1.4 Europe Organ Physiological Microsystem Forecast
10.1.5 Middle East & Africa Organ Physiological Microsystem Forecast
10.2 Americas Organ Physiological Microsystem Forecast by Country (2025-2030)
10.2.1 United States 麻豆原创 Organ Physiological Microsystem Forecast
10.2.2 Canada 麻豆原创 Organ Physiological Microsystem Forecast
10.2.3 Mexico 麻豆原创 Organ Physiological Microsystem Forecast
10.2.4 Brazil 麻豆原创 Organ Physiological Microsystem Forecast
10.3 APAC Organ Physiological Microsystem Forecast by Region (2025-2030)
10.3.1 China Organ Physiological Microsystem 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Organ Physiological Microsystem Forecast
10.3.3 Korea 麻豆原创 Organ Physiological Microsystem Forecast
10.3.4 Southeast Asia 麻豆原创 Organ Physiological Microsystem Forecast
10.3.5 India 麻豆原创 Organ Physiological Microsystem Forecast
10.3.6 Australia 麻豆原创 Organ Physiological Microsystem Forecast
10.4 Europe Organ Physiological Microsystem Forecast by Country (2025-2030)
10.4.1 Germany 麻豆原创 Organ Physiological Microsystem Forecast
10.4.2 France 麻豆原创 Organ Physiological Microsystem Forecast
10.4.3 UK 麻豆原创 Organ Physiological Microsystem Forecast
10.4.4 Italy 麻豆原创 Organ Physiological Microsystem Forecast
10.4.5 Russia 麻豆原创 Organ Physiological Microsystem Forecast
10.5 Middle East & Africa Organ Physiological Microsystem Forecast by Region (2025-2030)
10.5.1 Egypt 麻豆原创 Organ Physiological Microsystem Forecast
10.5.2 South Africa 麻豆原创 Organ Physiological Microsystem Forecast
10.5.3 Israel 麻豆原创 Organ Physiological Microsystem Forecast
10.5.4 Turkey 麻豆原创 Organ Physiological Microsystem Forecast
10.6 Global Organ Physiological Microsystem Forecast by Type (2025-2030)
10.7 Global Organ Physiological Microsystem Forecast by Application (2025-2030)
10.7.1 GCC Countries 麻豆原创 Organ Physiological Microsystem Forecast
11 Key Players Analysis
11.1 Emulate
11.1.1 Emulate Company Information
11.1.2 Emulate Organ Physiological Microsystem Product Offered
11.1.3 Emulate Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Emulate Main Business Overview
11.1.5 Emulate Latest Developments
11.2 Draper Laboratory
11.2.1 Draper Laboratory Company Information
11.2.2 Draper Laboratory Organ Physiological Microsystem Product Offered
11.2.3 Draper Laboratory Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Draper Laboratory Main Business Overview
11.2.5 Draper Laboratory Latest Developments
11.3 Mimetas
11.3.1 Mimetas Company Information
11.3.2 Mimetas Organ Physiological Microsystem Product Offered
11.3.3 Mimetas Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Mimetas Main Business Overview
11.3.5 Mimetas Latest Developments
11.4 TissUse
11.4.1 TissUse Company Information
11.4.2 TissUse Organ Physiological Microsystem Product Offered
11.4.3 TissUse Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 TissUse Main Business Overview
11.4.5 TissUse Latest Developments
11.5 CN Bio
11.5.1 CN Bio Company Information
11.5.2 CN Bio Organ Physiological Microsystem Product Offered
11.5.3 CN Bio Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 CN Bio Main Business Overview
11.5.5 CN Bio Latest Developments
11.6 Hesperos
11.6.1 Hesperos Company Information
11.6.2 Hesperos Organ Physiological Microsystem Product Offered
11.6.3 Hesperos Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Hesperos Main Business Overview
11.6.5 Hesperos Latest Developments
11.7 Nortis
11.7.1 Nortis Company Information
11.7.2 Nortis Organ Physiological Microsystem Product Offered
11.7.3 Nortis Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Nortis Main Business Overview
11.7.5 Nortis Latest Developments
11.8 Micronit
11.8.1 Micronit Company Information
11.8.2 Micronit Organ Physiological Microsystem Product Offered
11.8.3 Micronit Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Micronit Main Business Overview
11.8.5 Micronit Latest Developments
11.9 Kirkstall
11.9.1 Kirkstall Company Information
11.9.2 Kirkstall Organ Physiological Microsystem Product Offered
11.9.3 Kirkstall Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Kirkstall Main Business Overview
11.9.5 Kirkstall Latest Developments
11.10 Bi/ond
11.10.1 Bi/ond Company Information
11.10.2 Bi/ond Organ Physiological Microsystem Product Offered
11.10.3 Bi/ond Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Bi/ond Main Business Overview
11.10.5 Bi/ond Latest Developments
11.11 Cherry Biotech
11.11.1 Cherry Biotech Company Information
11.11.2 Cherry Biotech Organ Physiological Microsystem Product Offered
11.11.3 Cherry Biotech Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Cherry Biotech Main Business Overview
11.11.5 Cherry Biotech Latest Developments
11.12 Altis Biosystems
11.12.1 Altis Biosystems Company Information
11.12.2 Altis Biosystems Organ Physiological Microsystem Product Offered
11.12.3 Altis Biosystems Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 Altis Biosystems Main Business Overview
11.12.5 Altis Biosystems Latest Developments
11.13 SynVivo
11.13.1 SynVivo Company Information
11.13.2 SynVivo Organ Physiological Microsystem Product Offered
11.13.3 SynVivo Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 SynVivo Main Business Overview
11.13.5 SynVivo Latest Developments
11.14 NETRI
11.14.1 NETRI Company Information
11.14.2 NETRI Organ Physiological Microsystem Product Offered
11.14.3 NETRI Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 NETRI Main Business Overview
11.14.5 NETRI Latest Developments
11.15 Xona Microfluidics
11.15.1 Xona Microfluidics Company Information
11.15.2 Xona Microfluidics Organ Physiological Microsystem Product Offered
11.15.3 Xona Microfluidics Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 Xona Microfluidics Main Business Overview
11.15.5 Xona Microfluidics Latest Developments
11.16 InSphero
11.16.1 InSphero Company Information
11.16.2 InSphero Organ Physiological Microsystem Product Offered
11.16.3 InSphero Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.16.4 InSphero Main Business Overview
11.16.5 InSphero Latest Developments
11.17 AlveoliX
11.17.1 AlveoliX Company Information
11.17.2 AlveoliX Organ Physiological Microsystem Product Offered
11.17.3 AlveoliX Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.17.4 AlveoliX Main Business Overview
11.17.5 AlveoliX Latest Developments
11.18 BEOnchip
11.18.1 BEOnchip Company Information
11.18.2 BEOnchip Organ Physiological Microsystem Product Offered
11.18.3 BEOnchip Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.18.4 BEOnchip Main Business Overview
11.18.5 BEOnchip Latest Developments
11.19 BiomimX
11.19.1 BiomimX Company Information
11.19.2 BiomimX Organ Physiological Microsystem Product Offered
11.19.3 BiomimX Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.19.4 BiomimX Main Business Overview
11.19.5 BiomimX Latest Developments
11.20 Aracari
11.20.1 Aracari Company Information
11.20.2 Aracari Organ Physiological Microsystem Product Offered
11.20.3 Aracari Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.20.4 Aracari Main Business Overview
11.20.5 Aracari Latest Developments
11.21 Lena Biosciences
11.21.1 Lena Biosciences Company Information
11.21.2 Lena Biosciences Organ Physiological Microsystem Product Offered
11.21.3 Lena Biosciences Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.21.4 Lena Biosciences Main Business Overview
11.21.5 Lena Biosciences Latest Developments
11.22 Newcells Biotech
11.22.1 Newcells Biotech Company Information
11.22.2 Newcells Biotech Organ Physiological Microsystem Product Offered
11.22.3 Newcells Biotech Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.22.4 Newcells Biotech Main Business Overview
11.22.5 Newcells Biotech Latest Developments
11.23 React4Life
11.23.1 React4Life Company Information
11.23.2 React4Life Organ Physiological Microsystem Product Offered
11.23.3 React4Life Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.23.4 React4Life Main Business Overview
11.23.5 React4Life Latest Developments
11.24 TNO
11.24.1 TNO Company Information
11.24.2 TNO Organ Physiological Microsystem Product Offered
11.24.3 TNO Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.24.4 TNO Main Business Overview
11.24.5 TNO Latest Developments
11.25 Beijing Daxiang Biotech
11.25.1 Beijing Daxiang Biotech Company Information
11.25.2 Beijing Daxiang Biotech Organ Physiological Microsystem Product Offered
11.25.3 Beijing Daxiang Biotech Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.25.4 Beijing Daxiang Biotech Main Business Overview
11.25.5 Beijing Daxiang Biotech Latest Developments
11.26 Accurate International Biotechnology
11.26.1 Accurate International Biotechnology Company Information
11.26.2 Accurate International Biotechnology Organ Physiological Microsystem Product Offered
11.26.3 Accurate International Biotechnology Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.26.4 Accurate International Biotechnology Main Business Overview
11.26.5 Accurate International Biotechnology Latest Developments
11.27 D1med
11.27.1 D1med Company Information
11.27.2 D1med Organ Physiological Microsystem Product Offered
11.27.3 D1med Organ Physiological Microsystem Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.27.4 D1med Main Business Overview
11.27.5 D1med Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
